BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24028302)

  • 1. Analysis of plasma surfactant protein D levels in lung transplant recipients.
    Bejvl I; Weseslindtner L; Strassl R; Jaksch P; Kundi M; Klepetko W; Puchhammer-Stöckl E
    Transpl Infect Dis; 2013 Dec; 15(6):645-51. PubMed ID: 24028302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of serum surfactant protein D level prior to transplant for the development of bronchiolitis obliterans syndrome and idiopathic pneumonia syndrome following allogeneic hematopoietic stem cell transplantation.
    Nakane T; Nakamae H; Kamoi H; Koh H; Takeoka Y; Sakamoto E; Kanashima H; Nakamae M; Ohta K; Terada Y; Koh KR; Yamane T; Hino M
    Bone Marrow Transplant; 2008 Jul; 42(1):43-9. PubMed ID: 18347569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchoalveolar lavage fluid proteome in bronchiolitis obliterans syndrome: possible role for surfactant protein A in disease onset.
    Meloni F; Salvini R; Bardoni AM; Passadore I; Solari N; Vitulo P; Oggionni T; Viganò M; Pozzi E; Fietta AM
    J Heart Lung Transplant; 2007 Nov; 26(11):1135-43. PubMed ID: 18022079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
    Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
    J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for the development of obliterative bronchiolitis after lung transplantation.
    Girgis RE; Tu I; Berry GJ; Reichenspurner H; Valentine VG; Conte JV; Ting A; Johnstone I; Miller J; Robbins RC; Reitz BA; Theodore J
    J Heart Lung Transplant; 1996 Dec; 15(12):1200-8. PubMed ID: 8981205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and immunological evaluation of 12-month azithromycin therapy in chronic lung allograft rejection.
    Federica M; Nadia S; Monica M; Alessandro C; Tiberio O; Francesco B; Mario V; Maria FA
    Clin Transplant; 2011; 25(4):E381-9. PubMed ID: 21418327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation.
    Westall GP; Michaelides A; Williams TJ; Snell GI; Kotsimbos TC
    Transplantation; 2003 Jun; 75(12):2064-8. PubMed ID: 12829913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clara cell secretory protein and surfactant protein-D do not predict bronchiolitis obliterans syndrome after lung transplantation.
    Paantjens AW; Otten HG; van Ginkel WG; van Kessel DA; van den Bosch JM; Kwakkel-van Erp JM; van de Graaf EA
    Transplantation; 2010 Aug; 90(3):340-2. PubMed ID: 20683434
    [No Abstract]   [Full Text] [Related]  

  • 9. Lung transplantation for cystic fibrosis: 6-year follow-up.
    Quattrucci S; Rolla M; Cimino G; Bertasi S; Cingolani S; Scalercio F; Venuta F; Midulla F
    J Cyst Fibros; 2005 May; 4(2):107-14. PubMed ID: 15914093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?
    Moffatt-Bruce SD; Karamichalis J; Robbins RC; Whyte RI; Theodore J; Reitz BA
    Ann Thorac Surg; 2006 Jan; 81(1):286-91; discussion 291. PubMed ID: 16368382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Refractoriness" of airflow obstruction associated with isolated lymphocytic bronchiolitis/bronchitis in pulmonary allografts.
    Ross DJ; Marchevsky A; Kramer M; Kass RM
    J Heart Lung Transplant; 1997 Aug; 16(8):832-8. PubMed ID: 9286775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
    Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
    J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treated cytomegalovirus pneumonia is not associated with bronchiolitis obliterans syndrome.
    Tamm M; Aboyoun CL; Chhajed PN; Rainer S; Malouf MA; Glanville AR
    Am J Respir Crit Care Med; 2004 Nov; 170(10):1120-3. PubMed ID: 15297275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of D-dimer in lung transplant recipients with bronchiolitis obliterans syndrome.
    Shitrit D; Amital A; Fox B; Kramer MR
    Respir Med; 2008 Feb; 102(2):205-9. PubMed ID: 17976973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchiolitis obliterans syndrome development in lung transplantation patients.
    Parada MT; Alba A; Sepúlveda C
    Transplant Proc; 2010; 42(1):331-2. PubMed ID: 20172344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
    Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
    Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients.
    Kumar D; Husain S; Chen MH; Moussa G; Himsworth D; Manuel O; Studer S; Pakstis D; McCurry K; Doucette K; Pilewski J; Janeczko R; Humar A
    Transplantation; 2010 Apr; 89(8):1028-33. PubMed ID: 20075787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.
    Daud SA; Yusen RD; Meyers BF; Chakinala MM; Walter MJ; Aloush AA; Patterson GA; Trulock EP; Hachem RR
    Am J Respir Crit Care Med; 2007 Mar; 175(5):507-13. PubMed ID: 17158279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indoleamine 2,3-dioxygenase in lung allograft tolerance.
    Meloni F; Giuliano S; Solari N; Draghi P; Miserere S; Bardoni AM; Salvini R; Bini F; Fietta AM
    J Heart Lung Transplant; 2009 Nov; 28(11):1185-92. PubMed ID: 19783182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis.
    Sims MW; Beers MF; Ahya VN; Kawut SM; Sims KD; Lederer DJ; Palmer SM; Wille K; Lama VN; Shah PD; Orens JB; Bhorade S; Crespo M; Weinacker A; Demissie E; Bellamy S; Christie JD; Ware LB;
    Chest; 2011 Aug; 140(2):489-496. PubMed ID: 21349925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.